Abstract
The objective of this research project was to develop a nanoparticle drug delivery system using the biopolymer chitosan as the base component. The nanoparticles were produced through ionotropic gelation by flush mixing chitosan with counterions carrageenan and alginate. The nanoparticles were generated under a range of conditions to determine the effect of pH, chitosan concentration, carrageenan concentration, and alginate concentration on the nanoparticle characteristics of particle diameter, zeta potential, and particle size distribution. The encapsulation and controlled release of BSA from chitosan nanoparticles was also evaluated. The encapsulation of BSA was used as a model system for the controlled drug delivery from composite nanoparticles. The release profile indicated an initial burst in the first few hours of the trial, followed by a slower steady release over time. According to Korsmeyer-Peppas model, the release profile followed fickian diffusion.
Keywords: Alginate, BSA, biopolymers, composite nanoparticles, controlled release, chitosan, carrageenan.
Current Drug Delivery
Title:Characterization of Novel Composite Alginate Chitosan-Carrageenan Nanoparticles for Encapsulation of BSA as a Model Drug Delivery System
Volume: 12 Issue: 3
Author(s): Landi Cheng, Cody Bulmer and Argyrios Margaritis
Affiliation:
Keywords: Alginate, BSA, biopolymers, composite nanoparticles, controlled release, chitosan, carrageenan.
Abstract: The objective of this research project was to develop a nanoparticle drug delivery system using the biopolymer chitosan as the base component. The nanoparticles were produced through ionotropic gelation by flush mixing chitosan with counterions carrageenan and alginate. The nanoparticles were generated under a range of conditions to determine the effect of pH, chitosan concentration, carrageenan concentration, and alginate concentration on the nanoparticle characteristics of particle diameter, zeta potential, and particle size distribution. The encapsulation and controlled release of BSA from chitosan nanoparticles was also evaluated. The encapsulation of BSA was used as a model system for the controlled drug delivery from composite nanoparticles. The release profile indicated an initial burst in the first few hours of the trial, followed by a slower steady release over time. According to Korsmeyer-Peppas model, the release profile followed fickian diffusion.
Export Options
About this article
Cite this article as:
Cheng Landi, Bulmer Cody and Margaritis Argyrios, Characterization of Novel Composite Alginate Chitosan-Carrageenan Nanoparticles for Encapsulation of BSA as a Model Drug Delivery System, Current Drug Delivery 2015; 12 (3) . https://dx.doi.org/10.2174/1567201812666150114155948
DOI https://dx.doi.org/10.2174/1567201812666150114155948 |
Print ISSN 1567-2018 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5704 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Thymidine Phosphorylase and Fluoropyrimidines Efficacy: A Jekyl and Hyde Story
Current Medicinal Chemistry - Anti-Cancer Agents Detection of Predictive Markers for Therapeutic Stratification of Salivary Glands Tumors
Current Drug Targets Analytical Procedure for Determination of Cyclooxygenase-2 Inhibitors in Biological Fluids by High Performance Liquid Chromatography: A Review
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Tyrosine Kinases as Targets for Anti-Inflammatory Therapy
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Inflammasome, Inflammation and Cancer: An Interrelated Pathobiological Triad
Current Drug Targets Overcoming the Drug Resistance Problem with Second-Generation Tyrosine Kinase Inhibitors: From Enzymology to Structural Models
Current Medicinal Chemistry Tea and Health: Studies in Humans
Current Pharmaceutical Design Realizing the Potential of Health-Promoting Rosehips from Dogroses (Rosa sect. Caninae)
Current Bioactive Compounds Commercialization and Biomedical Applications of Pectin and Its Formulation in Pharmaceutical Drug Delivery System
Drug Delivery Letters Recent Advancements in Pharmacological Stent Therapy Using Polymeric Materials: Opportunities and Challenges
Current Drug Delivery Perspectives of Protein Kinase C (PKC) Inhibitors as Anti-Cancer Agents
Mini-Reviews in Medicinal Chemistry The Use of Anthracyclines for Therapy of CNS Tumors
Anti-Cancer Agents in Medicinal Chemistry Inhibition of Dipeptidyl Peptidase-4 (DPP-4): A Target to Treat Type 2 Diabetes
Current Enzyme Inhibition Identification of Bone Metastasis-associated Genes of Gastric Cancer by Genome-wide Transcriptional Profiling
Current Bioinformatics Cigarette Smoking, Metabolic Activation and Carcinogenesis
Current Drug Metabolism The Application of Fungal Beta-glucans for the Treatment of Colon Cancer
Anti-Cancer Agents in Medicinal Chemistry Pathophysiology and Pharmacological Targeting of Tumor-Induced Bone Disease: Current Status and Emerging Therapeutic Interventions
Current Medicinal Chemistry Recent Advances in the Design and Synthesis of c-Met Inhibitors as Anticancer Agents (2014-Present)
Current Medicinal Chemistry Phytochemical Profiles, Antioxidant and Antibacterial Activities of 11 Phellinus Mushrooms Collected in Thailand
The Natural Products Journal Bioactive N-Phenylimidazole Derivatives
Current Chemical Biology